ANNEX 2. Medicines to treat Drug Resistant (DR) TB Period drugs will be used: from (m/yr) to (m/yr) Preferred delivery date: Date/Month/Year Table 2 a : DR TB patients currently on treatment Table 2b: Number of adult DR cases to be treated *EXAMPLE: 8 Z-Km-Lfx-Eto-Cs/ 12 Z-Lfx-Eto-Cs ** This buffer stock percentage is applied to medicines quantities calculated for supply as indicated in "products and quantities requested" table below. Table 2c: Paediatric DR TB patients currently on treatment Table 2d: Number of paediatric DR cases to be treated
ANNEX 2. Medicines to treat Drug Resistant (DR) TB Period drugs will be used: from (m/yr) to (m/yr) Preferred delivery date: Date/Month/Year Table 2 a : DR TB patients currently on treatment Table 2b: Number of adult DR cases to be treated *EXAMPLE: 8 Z-Km-Lfx-Eto-Cs/ 12 Z-Lfx-Eto-Cs ** This buffer stock percentage is applied to medicines quantities calculated for supply as indicated in "products and quantities requested" table below. Table 2c: Paediatric DR TB patients currently on treatment Table 2d: Number of paediatric DR cases to be treated
Procurement%20Request%20Form%20medicines%202018_update%20Nov_final.docx